Home/Filings/4/0001628280-24-040035
4//SEC Filing

Napolitano Janet 4

Accession 0001628280-24-040035

CIK 0001706431other

Filed

Sep 9, 8:00 PM ET

Accepted

Sep 10, 4:28 PM ET

Size

5.3 KB

Accession

0001628280-24-040035

Insider Transaction Report

Form 4
Period: 2024-09-09
Transactions
  • Sale

    Common Stock

    2024-09-09$7.80/sh12,190$95,03211,616 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2024.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.49 to $7.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Issuer

Vir Biotechnology, Inc.

CIK 0001706431

Entity typeother

Related Parties

1
  • filerCIK 0001821008

Filing Metadata

Form type
4
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 4:28 PM ET
Size
5.3 KB